supported by grants from the National Natural Science Foundation of China (82270249).
To the Editor Congenital coronary artery anomalies(CAAs)are characterized by abnormalities in the origins,course,or termination of the three main epicardial coronary arteries[1,2].These anomalies can result in a spect...
BACKGROUND Loneliness and isolation are associated with multiple cardiovascular diseases(CVDs),but there is a lack of research on whether they were causally linked.We conducted a Mendelian Randomization(MR)study to ex...
Guangdong Medical Foundation:Exploring the Mechanism of Shenshu Guanxin Formula in Intervention of Myocardial Ischemia Based on MiR-24 Mediated Bim/Caspase Apoptosis Signal Pathway (No.A2021349);the Fundamental Research Funds for the Central Universities:Exploring the Intervention of Shenshu Guanxin Formula on Myocardial Ischemia Based on MiR-24 Mediated Bim/Caspase Apoptosis Signal Pathway Mechanism Research (No.21621062);the Science and Technology Innovation Projects of Shenzhen:to Study the Mechanism of Hesperidin in Improving Heart Failure Based on Myocardial Inflammation Mediated by Mt DNA-s GAS-STING Signaling Pathway (No.JCYJ20220530144212026)
OBJECTIVE:To assess the effectivess of Shenshu Guanxin recipe granules(参术冠心方颗粒,SGR)in improving exercise tolerance and the quality of life in patients with Stable Angina Pectoris(SAP).METHODS:A total of 189 pat...
Objective To analyze differential expression of MicroRNA(miRNA)in serum exosomes of unstable angina(UA)patients.Methods Peripheral blood of 115UA patients,including 59 patients with qi deficiency and blood stasis synd...
Objective To investigate the clinical efficacy of the Guanxinning tablet on the prethrombotic state in older adults with stable angina pectoris.Methods In this study,80 elderly patients with coronary heart disease and...
Sinus bradycardia is a common clinical problem with a population prevalence of approximately 4/1000.[1]Most patients are asymptomatic,but some patients experience symptoms such as fatigue,dizziness,exercise intoleranc...